Key result
S-nitrosylation of STIM1 by neuronal nitric oxide synthase suppresses oligomerization via enhanced luminal domain stability and inhibits store-operated Ca2+ entry in cardiomyocytes.
S-nitrosylation of STIM1 by nNOS at Cys49 and Cys56 suppresses its oligomerization and inhibits store-operated Ca2+ entry in cardiomyocytes.
Hypothesis-generating for nNOS-STIM1 regulation of cardiomyocyte Ca2+ entry; human relevance and therapeutic potential remain untested.
Store-operated Ca 2+ entry (SOCE) mediated by stromal interacting molecule-1 (STIM1) and Orai1 represents a major route of Ca 2+ entry in mammalian cells and is initiated by STIM1 oligomerization in the endoplasmic or sarcoplasmic reticulum (ER/SR). However, the effects of nitric oxide (NO) on STIM1 function are unknown. Neuronal NO synthase (nNOS) is located in the SR of cardiomyocytes. Here, we show that STIM1 is susceptible to S-nitrosylation. nNOS deficiency or inhibition enhanced Ca 2+ release-activated Ca 2+ channel current ( I CRAC ) and SOCE in cardiomyocytes. Consistently, NO donor S-nitrosoglutathione (GSNO) inhibited STIM1 puncta formation and I CRAC in HEK293 cells, but this effect was absent in cells expressing the Cys49Ser/Cys56Ser STIM1 double mutant. Furthermore, NO donors caused Cys49 and Cys56-specific structural changes associated with reduced protein backbone mobility, increased thermal stability and suppressed Ca 2+ -depletion-dependent oligomerization of the luminal Ca 2+ -sensing region of STIM1. Collectively, our data show that S-nitrosylation of STIM1 suppresses oligomerization via enhanced luminal domain stability and rigidity, and inhibits SOCE in cardiomyocytes.
No takes yet. Share an insight, caveat, or question.
Gui et al. (2018) studied this question. S-nitrosylation / NO donors (GSNO) vs. nNOS deficiency or inhibition / Cys49Ser/Cys56Ser STIM1 double mutant was evaluated on Store-operated Ca2+ entry (SOCE) and Ca2+ release-activated Ca2+ channel current (ICRAC). S-nitrosylation of STIM1 by neuronal nitric oxide synthase suppresses oligomerization via enhanced luminal domain stability and inhibits store-operated Ca2+ entry in cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: